PubRank

Mengchao Wu

Author PubWeight™ 101.01‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Prognostic nomogram for intrahepatic cholangiocarcinoma after partial hepatectomy. J Clin Oncol 2013 2.16
2 GWAS identifies novel susceptibility loci on 6p21.32 and 21q21.3 for hepatocellular carcinoma in chronic hepatitis B virus carriers. PLoS Genet 2012 1.86
3 Methylation profiling of twenty promoter-CpG islands of genes which may contribute to hepatocellular carcinogenesis. BMC Cancer 2002 1.63
4 Synergistic effect of mTOR inhibitor rapamycin and fluorouracil in inducing apoptosis and cell senescence in hepatocarcinoma cells. Cancer Biol Ther 2007 1.58
5 Sphere-forming cell subpopulations with cancer stem cell properties in human hepatoma cell lines. BMC Gastroenterol 2011 1.43
6 Hypoxia-induced autophagy contributes to the chemoresistance of hepatocellular carcinoma cells. Autophagy 2009 1.39
7 MicroRNA-21 suppresses PTEN and hSulf-1 expression and promotes hepatocellular carcinoma progression through AKT/ERK pathways. Cancer Lett 2013 1.38
8 MicroRNA-135a contributes to the development of portal vein tumor thrombus by promoting metastasis in hepatocellular carcinoma. J Hepatol 2011 1.37
9 Prognostic significance of AMPK activation and therapeutic effects of metformin in hepatocellular carcinoma. Clin Cancer Res 2013 1.32
10 The minimum LOH region defined on chromosome 17p13.3 in human hepatocellular carcinoma with gene content analysis. Cancer Lett 2003 1.32
11 Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis. Gastroenterology 2008 1.27
12 Perioperative reactivation of hepatitis B virus replication in patients undergoing partial hepatectomy for hepatocellular carcinoma. J Gastroenterol Hepatol 2012 1.23
13 MiR-20a triggers metastasis of gallbladder carcinoma. J Hepatol 2013 1.22
14 Down-regulation of growth arrest DNA damage-inducible gene 45beta expression is associated with human hepatocellular carcinoma. Am J Pathol 2003 1.17
15 Cyclin G1-mediated epithelial-mesenchymal transition via phosphoinositide 3-kinase/Akt signaling facilitates liver cancer progression. Hepatology 2012 1.17
16 Epigenetic silence of ankyrin-repeat-containing, SH3-domain-containing, and proline-rich-region- containing protein 1 (ASPP1) and ASPP2 genes promotes tumor growth in hepatitis B virus-positive hepatocellular carcinoma. Hepatology 2010 1.16
17 Decreased TIP30 expression promotes tumor metastasis in lung cancer. Am J Pathol 2009 1.16
18 TIP30 induces apoptosis under oxidative stress through stabilization of p53 messenger RNA in human hepatocellular carcinoma. Cancer Res 2008 1.15
19 Roles of chemokine receptor 4 (CXCR4) and chemokine ligand 12 (CXCL12) in metastasis of hepatocellular carcinoma cells. Cell Mol Immunol 2008 1.15
20 Hepatitis B virus-associated intrahepatic cholangiocarcinoma and hepatocellular carcinoma may hold common disease process for carcinogenesis. Eur J Cancer 2010 1.12
21 Increased p38-MAPK is responsible for chemotherapy resistance in human gastric cancer cells. BMC Cancer 2008 1.11
22 CpG island methylator phenotype association with upregulated telomerase activity in hepatocellular carcinoma. Int J Cancer 2008 1.11
23 Adjuvant therapy with capecitabine postpones recurrence of hepatocellular carcinoma after curative resection: a randomized controlled trial. Ann Surg Oncol 2010 1.10
24 Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma. Clin Cancer Res 2008 1.09
25 Use of adenovirus-delivered siRNA to target oncoprotein p28GANK in hepatocellular carcinoma. Gastroenterology 2005 1.09
26 Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma. Hepatology 2008 1.09
27 A rare case of rapid growth of exophytic gastrointestinal stromal tumor of the stomach. Dig Dis Sci 2005 1.05
28 TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU. Hepatology 2006 1.03
29 Proteome analysis of hepatocellular carcinoma by laser capture microdissection. Proteomics 2006 1.02
30 Mesenchymal stem cells in inflammation microenvironment accelerates hepatocellular carcinoma metastasis by inducing epithelial-mesenchymal transition. PLoS One 2012 1.01
31 Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma. Ann Surg Oncol 2011 0.99
32 Predictive factors for complications after pancreaticoduodenectomy. J Surg Res 2007 0.99
33 Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) in a single patient: a clinicopathologic study of 35 resected cases. J Gastroenterol Hepatol 2013 0.98
34 Background progenitor activation is associated with recurrence after hepatectomy of combined hepatocellular-cholangiocarcinoma. Hepatology 2012 0.98
35 Immunosuppressive effect of bone marrow-derived mesenchymal stem cells in inflammatory microenvironment favours the growth of B16 melanoma cells. J Cell Mol Med 2011 0.98
36 Gene therapy using adenovirus-mediated full-length anti-HER-2 antibody for HER-2 overexpression cancers. Clin Cancer Res 2006 0.98
37 Inhibitory effect of Survivin promoter-regulated oncolytic adenovirus carrying P53 gene against gallbladder cancer. Mol Oncol 2011 0.96
38 Use of microRNA Let-7 to control the replication specificity of oncolytic adenovirus in hepatocellular carcinoma cells. PLoS One 2011 0.95
39 OCT4 positively regulates Survivin expression to promote cancer cell proliferation and leads to poor prognosis in esophageal squamous cell carcinoma. PLoS One 2012 0.95
40 Distal bile duct carcinoma: prognostic factors after curative surgery. A series of 112 cases. Ann Surg Oncol 2006 0.94
41 P16 reactivation induces anoikis and exhibits antitumour potency by downregulating Akt/survivin signalling in hepatocellular carcinoma cells. Gut 2010 0.93
42 Effective gene-viral therapy for telomerase-positive cancers by selective replicative-competent adenovirus combining with endostatin gene. Cancer Res 2004 0.93
43 Autophagy in hypoxia protects cancer cells against apoptosis induced by nutrient deprivation through a Beclin1-dependent way in hepatocellular carcinoma. J Cell Biochem 2011 0.93
44 Increased safety with preserved antitumoral efficacy on hepatocellular carcinoma with dual-regulated oncolytic adenovirus. Clin Cancer Res 2006 0.93
45 CpG island methylator phenotype association with elevated serum alpha-fetoprotein level in hepatocellular carcinoma. Clin Cancer Res 2007 0.93
46 OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma. BMC Cancer 2013 0.92
47 [Percutaneous radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinoma]. Zhonghua Wai Ke Za Zhi 2002 0.92
48 Hepatic stellate cells secreted hepatocyte growth factor contributes to the chemoresistance of hepatocellular carcinoma. PLoS One 2013 0.91
49 CD133/prominin-1-mediated autophagy and glucose uptake beneficial for hepatoma cell survival. PLoS One 2013 0.91
50 Hepatitis B virus X protein enhances cisplatin-induced hepatotoxicity via a mechanism involving degradation of Mcl-1. J Virol 2011 0.91
51 Hepatitis B x antigen up-regulates vascular endothelial growth factor receptor 3 in hepatocarcinogenesis. Hepatology 2007 0.89
52 5/35 fiber-modified conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells. Hum Gene Ther 2011 0.89
53 Methylation-related silencing of p14ARF gene correlates with telomerase activity and mRNA expression of human telomerase reverse transcriptase in hepatocellular carcinoma. J Surg Oncol 2008 0.88
54 Reactive lymphoid hyperplasia of the liver: a clinicopathological study of 7 cases. HPB Surg 2012 0.88
55 Correlation of CpG island methylator phenotype with poor prognosis in hepatocellular carcinoma. Exp Mol Pathol 2009 0.88
56 hSulf-1 gene exhibits anticancer efficacy through negatively regulating VEGFR-2 signaling in human cancers. PLoS One 2011 0.87
57 Screening of autoantibodies as potential biomarkers for hepatocellular carcinoma by using T7 phase display system. Cancer Epidemiol 2011 0.87
58 A novel triple-regulated oncolytic adenovirus carrying p53 gene exerts potent antitumor efficacy on common human solid cancers. Mol Cancer Ther 2008 0.85
59 Toxicology profiles of a novel p53-armed replication-competent oncolytic adenovirus in rodents, felids, and nonhuman primates. Toxicol Sci 2008 0.85
60 Icaritin induces cell death in activated hepatic stellate cells through mitochondrial activated apoptosis and ameliorates the development of liver fibrosis in rats. J Ethnopharmacol 2011 0.84
61 siRNA-mediated inhibition of hTERT enhances chemosensitivity of hepatocellular carcinoma. Cancer Biol Ther 2008 0.84
62 Gene-viral cancer therapy using dual-regulated oncolytic adenovirus with antiangiogenesis gene for increased efficacy. Mol Cancer Res 2008 0.84
63 Interleukin-1β/Iinterleukin-1 receptor-associated kinase 1 inflammatory signaling contributes to persistent Gankyrin activation during hepatocarcinogenesis. Hepatology 2015 0.84
64 Expression of the chemokine receptor CXCR4 in human hepatocellular carcinoma and its role in portal vein tumor thrombus. J Exp Clin Cancer Res 2010 0.84
65 Management and surgical treatment for focal nodular hyperplasia in children. Pediatr Surg Int 2008 0.83
66 Cyclin D1 induction by benzo[a]pyrene-7,8-diol-9,10-epoxide via the phosphatidylinositol 3-kinase/Akt/MAPK- and p70s6k-dependent pathway promotes cell transformation and tumorigenesis. J Biol Chem 2009 0.83
67 Proteomics analysis of distinct portal vein tumor thrombi in hepatocellular carcinoma patients. J Proteome Res 2010 0.83
68 Low glucose promotes CD133mAb-elicited cell death via inhibition of autophagy in hepatocarcinoma cells. Cancer Lett 2013 0.83
69 Coupled down-regulation of mTOR and telomerase activity during fluorouracil-induced apoptosis of hepatocarcinoma cells. BMC Cancer 2007 0.82
70 Immune gene-viral therapy with triplex efficacy mediated by oncolytic adenovirus carrying an interferon-gamma gene yields efficient antitumor activity in immunodeficient and immunocompetent mice. Mol Ther 2006 0.82
71 Tumor necrosis factor-alpha promotes tumor growth by inducing vascular endothelial growth factor. Cancer Invest 2011 0.82
72 p28GANK knockdown-derived reactive oxygen species induces apoptosis through mitochondrial dysfunction mediated by p38 in HepG2 cells. Int J Oncol 2008 0.82
73 mda-7/IL-24 induces apoptosis in human HepG2 hepatoma cells by endoplasmic reticulum stress. Oncol Rep 2008 0.82
74 A novel diagnostic marker, p28GANK distinguishes hepatocellular carcinoma from potential mimics. J Cancer Res Clin Oncol 2004 0.81
75 Lentivirally engineered dendritic cells activate AFP-specific T cells which inhibit hepatocellular carcinoma growth in vitro and in vivo. Int J Oncol 2011 0.81
76 Peritumoral ductular reaction: a poor postoperative prognostic factor for hepatocellular carcinoma. BMC Cancer 2014 0.81
77 Human sulfatase-1 inhibits the migration and proliferation of SMMC-7721 hepatocellular carcinoma cells by downregulating the growth factor signaling. Hepatol Res 2012 0.81
78 Safety and efficacy of trisectionectomy for hepatocellular carcinoma. ANZ J Surg 2011 0.81
79 Hepatic angiomyolipoma: clinical, imaging and pathological features in 178 cases. Med Oncol 2013 0.80
80 Wnt/beta-catenin signaling in embryonic stem cell converted tumor cells. J Transl Med 2012 0.80
81 Serum profiling based on fucosylated glycoproteins for differentiating between chronic hepatitis B and hepatocellular carcinoma. Biochem Biophys Res Commun 2012 0.80
82 Early recurrence after curative resection in oligonodular hepatocellular carcinoma. Hepatogastroenterology 2013 0.79
83 Establishment of mouse teratocarcinomas stem cells line and screening genes responsible for malignancy. PLoS One 2012 0.79
84 Germ-line-competent embryonic stem cells of the Chinese Kunming mouse strain with long-term self-renewal ability. Cell Reprogram 2013 0.79
85 Potent antitumor efficacy of an E1B 55kDa-deficient adenovirus carrying murine endostatin in hepatocellular carcinoma. Int J Cancer 2005 0.79
86 The combination of an oxygen-dependent degradation domain-regulated adenovirus expressing the chemokine RANTES/CCL5 and NK-92 cells exerts enhanced antitumor activity in hepatocellular carcinoma. Oncol Rep 2012 0.78
87 Bevacizumab attenuates hepatic fibrosis in rats by inhibiting activation of hepatic stellate cells. PLoS One 2013 0.78
88 Characterization of two novel cell lines with distinct heterogeneity derived from a single human bile duct carcinoma. PLoS One 2013 0.78
89 Eradication of hepatoma and colon cancer in mice with Flt3L gene therapy in combination with 5-FU. Cancer Immunol Immunother 2007 0.78
90 An anti-preS2 antibody protects human hepatocytes from hepatitis B virus infection. Acta Gastroenterol Belg 2009 0.78
91 Generation of adenovirus-mediated anti-CD20 antibody and its effect on B-cell deletion in mice and nonhuman primate cynomolgus monkey. Mol Cancer Ther 2008 0.78
92 [Correlation between midkine protein overexpression and intrahepatic metastasis in hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi 2002 0.78
93 Inhibition of autophagy may suppress the development of hepatoblastoma. FEBS J 2011 0.78
94 Inhibition of tumorigenesis and invasion of hepatocellular carcinoma by siRNA-mediated silencing of the livin gene. Mol Med Rep 2010 0.77
95 [Transarterial embolization for hemorrhage due to spontaneous rupture in hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi 2002 0.77
96 Conversion of rat embryonic stem cells into neural precursors in chemical-defined medium. Biochem Biophys Res Commun 2013 0.77
97 [Gene transfer of murine Flt3 ligand mediated by adenoviral vector efficiently induces growth inhibition of murine liver cancer]. Zhonghua Yi Xue Za Zhi 2002 0.76
98 Gene-viral vectors: a promising way to target tumor cells and express anticancer genes simultaneously. Chin Med J (Engl) 2002 0.76
99 [Curative effect of percutaneous microwave coagulation therapy for hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi 2002 0.76
100 A prognostic scoring system for patients with multiple hepatocellular carcinomas treated by hepatectomy. Ann Surg Oncol 2014 0.76
101 [Liver cancer: new strategy of molecular pathological diagnosis and new mode of clinical therapy]. Zhonghua Yi Xue Za Zhi 2014 0.76
102 Successful en bloc resection of recurrent hepatocellular carcinoma directly invading the abdominal wall: a case report. J Med Case Rep 2015 0.75
103 Tumor necrosis factor-α attenuates starvation-induced apoptosis through upregulation of ferritin heavy chain in hepatocellular carcinoma cells. BMC Cancer 2013 0.75
104 Intratumoral hepatic stellate cells as a poor prognostic marker and a new treatment target for hepatocellular carcinoma. PLoS One 2013 0.75
105 Surgical treatment of double primary liver cancer: An observational study for a rare type of tumor. Medicine (Baltimore) 2016 0.75
106 Post-hepatectomy haemorrhage: a single-centre experience. HPB (Oxford) 2014 0.75
107 The hepatoprotective effect of hypothermic perfusion of normal saline in period of inflow occlusion of liver in rats. J Surg Res 2009 0.75
108 [Development of gene-viral vector and its anti-tumor effect, a primary study]. Zhonghua Yi Xue Za Zhi 2002 0.75
109 [Injection of NKG5SV gene to inhibit growth and metastasis of hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi 2002 0.75
110 [Hypoxia augments the killing effect of herpes simplex virus thymidine kinase gene expression actuated by the promoter of the vascular endothelial growth factor gene on human hepatocellular tumor cells]. Zhonghua Zhong Liu Za Zhi 2002 0.75
111 Structural basis of interaction between protein tyrosine phosphatase PCP-2 and beta-catenin. Sci China C Life Sci 2005 0.75
112 [Antitumor immunity elicited by 4-1BBL gene transfected Hepa1-6 in vivo]. Zhonghua Gan Zang Bing Za Zhi 2002 0.75
113 [Clone of a novel liver cancer associated gene and analysis of the secondary structures of the predicted protein]. Zhonghua Gan Zang Bing Za Zhi 2002 0.75
114 Superior approach for the exclusion of hepatic veins in major liver resection: a safe and easy technique. Surg Today 2009 0.75
115 [Resection of right or total hepatic caudate lobe including paracaval portion]. Zhonghua Wai Ke Za Zhi 2002 0.75
116 A large asymptomatic hepatic mass. Liver Int 2011 0.75
117 [The in vivo antitumor activity of murine liver tumor vaccine expressing MIP-1alpha]. Zhonghua Wai Ke Za Zhi 2002 0.75
118 [The functional and phenotypic analysis of T lymphocytes under stimulation of THANK]. Zhonghua Yi Xue Za Zhi 2002 0.75
119 A retrospective controlled analysis of outcomes of using integrated therapy of traditional Chinese and modern medicines for primary liver cancer of middle and late stages. J Altern Complement Med 2006 0.75
120 Clinical studies of laser ablation in treatment of primary liver carcinoma-associated portal vein tumor thrombus. Clin Appl Thromb Hemost 2009 0.75
121 SIRPalpha negatively regulates differentiation of PC12 cell. Brain Res Mol Brain Res 2005 0.75
122 [The effect of postoperative transcatheter hepatic arterial chemoembolization on disease-free survival after hepatectomy for hepatocellular carcinoma]. Zhonghua Wai Ke Za Zhi 2002 0.75
123 [Radiotherapy with (186)Re-lipiodol II for primary liver cancer patients]. Zhonghua Wai Ke Za Zhi 2002 0.75